Stenting In Heart Attack Patients Cleared By FDA; Guidant’s Multi-Link Is First

Guidant is now the only company with a coronary stent indicated for use in heart attack patients in the U.S. The firm announced Aug. 14 that the Multi-Link stent platform received FDA approval via PMA supplement